Adeshwar Meditex Ltd
Incorporated in 2007, Adeshwar Meditex Ltd is a manufacturer and exporter of all forms of first aid kits, surgical dressing, surgical plastics and other medical disposables[1]
- Market Cap ₹ 27.6 Cr.
- Current Price ₹ 19.1
- High / Low ₹ 26.5 / 15.0
- Stock P/E 13.9
- Book Value ₹ 25.6
- Dividend Yield 0.00 %
- ROCE 8.27 %
- ROE 5.51 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.75 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 8.33% over past five years.
- Company has a low return on equity of 5.95% over last 3 years.
- Company has high debtors of 153 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
58.60 | 52.92 | 56.12 | 65.97 | 64.76 | 82.36 | 79.85 | 83.71 | |
52.96 | 47.44 | 50.64 | 61.22 | 61.39 | 77.14 | 74.66 | 79.29 | |
Operating Profit | 5.64 | 5.48 | 5.48 | 4.75 | 3.37 | 5.22 | 5.19 | 4.42 |
OPM % | 9.62% | 10.36% | 9.76% | 7.20% | 5.20% | 6.34% | 6.50% | 5.28% |
0.10 | 0.25 | 0.28 | 0.13 | 0.23 | 0.31 | 0.13 | 0.26 | |
Interest | 1.78 | 2.23 | 2.52 | 2.19 | 2.03 | 2.09 | 1.93 | 1.39 |
Depreciation | 0.36 | 0.35 | 0.34 | 0.35 | 0.38 | 0.53 | 0.60 | 0.50 |
Profit before tax | 3.60 | 3.15 | 2.90 | 2.34 | 1.19 | 2.91 | 2.79 | 2.79 |
Tax % | 29.72% | 28.25% | 27.24% | 28.63% | 33.61% | 28.52% | 27.96% | 26.16% |
2.54 | 2.26 | 2.12 | 1.68 | 0.79 | 2.07 | 2.01 | 2.07 | |
EPS in Rs | 5.10 | 4.54 | 4.03 | 1.60 | 0.55 | 1.43 | 1.39 | 1.43 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 8% |
3 Years: | 9% |
TTM: | 5% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -1% |
3 Years: | 36% |
TTM: | -1% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -10% |
1 Year: | -10% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 6% |
3 Years: | 6% |
Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 4.98 | 4.98 | 5.27 | 10.53 | 14.43 | 14.43 | 14.43 | 14.43 |
Reserves | 8.55 | 10.81 | 13.64 | 10.05 | 16.52 | 18.48 | 20.48 | 22.53 |
11.58 | 19.92 | 21.32 | 22.45 | 18.99 | 16.43 | 13.89 | 12.45 | |
7.33 | 5.79 | 14.57 | 19.27 | 22.63 | 17.67 | 15.23 | 22.79 | |
Total Liabilities | 32.44 | 41.50 | 54.80 | 62.30 | 72.57 | 67.01 | 64.03 | 72.20 |
2.36 | 2.44 | 2.28 | 2.24 | 3.03 | 3.70 | 3.53 | 2.95 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.02 | 0.04 | 0.08 | 0.08 | 0.10 | 0.10 | 0.10 | 0.00 |
30.06 | 39.02 | 52.44 | 59.98 | 69.44 | 63.21 | 60.40 | 69.25 | |
Total Assets | 32.44 | 41.50 | 54.80 | 62.30 | 72.57 | 67.01 | 64.03 | 72.20 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
-0.99 | 3.15 | -2.44 | 5.77 | 3.84 | 3.80 | |||
1.58 | -0.71 | -1.16 | -1.16 | -0.22 | 0.51 | |||
-0.07 | -3.11 | 4.44 | -4.63 | -4.36 | -2.66 | |||
Net Cash Flow | 0.53 | -0.66 | 0.85 | -0.02 | -0.75 | 1.65 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 108.69 | 134.63 | 181.26 | 150.82 | 183.06 | 123.78 | 115.51 | 152.52 |
Inventory Days | 64.44 | 112.51 | 119.36 | 174.35 | 168.24 | 127.72 | 138.71 | 126.64 |
Days Payable | 43.11 | 38.76 | 104.70 | 119.86 | 138.51 | 88.18 | 75.97 | 104.03 |
Cash Conversion Cycle | 130.02 | 208.39 | 195.93 | 205.31 | 212.79 | 163.33 | 178.25 | 175.13 |
Working Capital Days | 129.43 | 108.29 | 124.03 | 111.49 | 147.05 | 116.60 | 129.04 | 135.78 |
ROCE % | 17.69% | 14.27% | 11.22% | 6.93% | 10.07% | 9.62% | 8.27% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Oct - No dematerialisation requests received for quarter ended 30 September 2025.
-
Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
27 Sep - M/s J N Gupta & Co. LLP resigned as statutory auditor, effective September 26, 2025.
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
26 Sep - 18th AGM on 25 Sep 2025: all resolutions approved; scrutinizer Deep Shukla & Associates; voting results attached.
-
Closure of Trading Window
25 Sep - Trading window closed from Oct 1, 2025 for unaudited H1 results (Sept 30, 2025); reopens 48 hours after results.
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
25 Sep - 18th AGM on 25 Sep 2025: adopted FY2024-25 financials; re-appointed Shailesh Rajpure; appointed Satish Chudekar.
Business Overview:[1][2]
Company is a WHO cGMP, CE, ISO 9001-2008 Certified manufacturer and exporter of sterile surgical wound dressing products and medical disposables. It deals in all kinds of surgical, pharmaceutical, medicine items including first aid kits, surgical dressings including sterile medicated wound dressings, sterile advanced hemostatic dressings, chitosan, oxidized cellulose and gelatin sponges, medical bandages, medical kits, Home Based New Born (HBNC) and other kits, face masks, and dealing in various items and Turnkey projects for all of the above products and other ancillary business